SCHEMBL1015881

SCHEMBL1015881

COC(=O)c1cc(Cl)ccc1NC(=O)CSCC(=O)Nc1ccc(C2CCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.58
▸ KLF5 Q13887 1/20 0.58
▸ ALDH1A1 P00352 6/20 0.54
▸ HPGD P15428 3/20 0.54
▸ SERPINE1 P05121 3/20 0.51
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RORC P51449 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013722 0.89 SERPINE1 (0.52) MITFKLF5ALDH1A1HPGDSERPINE1
SCHEMBL1015323 0.89 SERPINE1 (0.65) MITFKLF5ALDH1A1HPGDSERPINE1
SCHEMBL1013563 0.84 KMT2A (0.53) MITFALDH1A1HPGDNPC1RAB9A
SCHEMBL418773 0.80 SERPINE1 (0.77) ALDH1A1HPGDSERPINE1HSD17B10
SCHEMBL1014502 0.79 SERPINE1 (0.52) ALDH1A1HPGDSERPINE1SMN1; SMN2KMT2A
SCHEMBL1015276 0.79 SERPINE1 (0.65) MITFKLF5ALDH1A1HPGDSERPINE1
SCHEMBL1016218 0.79 KDM4E (0.60) ALDH1A1TP53L3MBTL1KMT2AMAPT
SCHEMBL1012592 0.78 SERPINE1 (0.64) MITFKLF5ALDH1A1HPGDSERPINE1
SCHEMBL1012593 0.77 SERPINE1 (0.52) MITFKLF5ALDH1A1HPGDSERPINE1
SCHEMBL419440 0.76 SERPINE1 (0.52) ALDH1A1SERPINE1NPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 — — US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 — — US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 MITF 1152/4885KLF5 1331/4885ALDH1A1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback